Hannover Rueck SE (HVRRY) AI Stock Analysis

• Market Cap: $36.34B
• Dividend Yield: 3.57%
• Average Volume (3M): 1.17K
• Price to Earnings (P/E): 12.6
• Beta (1Y): 0.36
• Revenue Growth: 4.35%
• EPS Growth: 12.64%
• Country: US
• Employees: 3,895
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Reinsurance
• EPS (TTM): 1.08
• Shares Outstanding: 723,582,800
• 10 Day Avg. Volume: 1,549
• 30 Day Avg. Volume: 1,170
• PEG Ratio: 1.41
• Price to Book (P/B): 2.48
• Price to Sales (P/S): 1.16
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 0.95
• Enterprise Value/Revenue: 1.41
• Enterprise Value/Gross Profit: 1.41
• Enterprise Value/Ebitda: 3.62
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 4.41
• Revenue Forecast (FY): $32.18B

• Rating: 69 Neutral
• Price Target: $55.00 ▲(16.35% Upside)
• Action: Downgraded Date: 03/15/26
• Date: Action: Downgraded 03/15/26

The score is driven primarily by a decent but somewhat clouded financial profile (2025 data inconsistencies) and a positive earnings-call outlook with strong solvency and higher 2026 targets. Supportive valuation (moderate P/E and solid yield) helps, while technical signals remain only mildly positive and not strongly trend-confirming.

Positive Factors

Strong Solvency / Capitalization

A reported solvency ratio of 259% provides a durable capital buffer to absorb large catastrophe losses, support retrocession and underwriting capacity, and maintain regulatory headroom. This strong capitalization underpins multi‑year risk appetite and supports disciplined growth and capital returns.

Diversified P&C and Life & Health Franchise

Concurrent mid‑teens L&H new business growth and strong P&C expansion indicate balanced revenue sources across short‑ and long‑tail lines. This diversification smooths underwriting cycle volatility, supports cross‑selling, and provides multiple durable avenues for organic revenue growth over several quarters to years.

Historically Strong Cash Generation and Manageable Leverage

Multi‑year operating cash flows in the low‑single‑digit billions and historically moderate debt/equity (≈0.3–0.6) show resilient cash generation and reasonable capitalization. That steady cash profile supports claims payments, reinvestment, and strategic capital deployment even through normal industry cycles.

Negative Factors

2025 Data and Income Statement Inconsistencies

Sharp 2025 reporting anomalies—extreme revenue swings and unusually high margins in places—reduce confidence in recent results. Persistent data or reporting inconsistencies impair reliable trend analysis and forecasting, obscure reserve adequacy and earnings quality, and complicate medium‑term fundamental assessment.

Realized Fixed‑Income Losses

Crystallizing roughly EUR 300m+ of fixed‑income losses to reposition the portfolio reduces near‑term investment income and consumes capital cushions. While strategic to lock higher yields, realized losses weigh on solvency and earnings until reinvestment gains accrue, creating a durable headwind to short‑to‑medium‑term returns.

Underwriting Reserve Pressure & Regional Challenges

A negative P&C run‑off of EUR 465m and morbidity issues in Greater China reflect reserve strengthening and adverse regional experience. These developments increase underwriting volatility, can raise combined‑ratio pressure, and may require higher risk adjustments or capital for long‑tail exposures over the next several quarters.

Hannover Rueck SE Business Overview & Revenue Model

Company Description

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The company offers property, casualty, facultative, catastrophe XL, structured reinsurance, and insurance-linked securities. It also provides risk solutions for agricultural, livestock, and bloodstock businesses; aviation and space business; and marine and offshore energy business, as well as credit, surety, and political risks reinsurance products. In addition, the company offers group and individual credit life, enhanced annuities, group life and health, and Takaful reinsurance products; and risk solutions in the areas of critical illness, disability, health, longevity, long term care, mortality, and morbidity. Further, it provides various financial solutions, including new-business financing; monetization of embedded value; reserve and solvency relief; and divestiture of non-core businesses. The company was formerly known as Hannover Rückversicherung AG and changed its name to Hannover Rück SE in March 2013. The company was founded in 1966 and is headquartered in Hanover, Germany. Hannover Rück SE is a subsidiary of Talanx AG.

How the Company Makes Money

Hannover Rueck primarily makes money through (1) underwriting income from reinsurance and (2) investment income on the assets it holds to support reserves and capital. 1) Reinsurance underwriting revenue (core business): - Premiums: The company earns reinsurance premiums from insurance companies (cedants) in exchange for assuming a portion of their risk. Premium volume is driven by renewals and new treaty and facultative business written across property & casualty and life & health segments. - Claims and benefits: Profitability depends on whether premiums exceed claims/benefits paid plus changes in reserves. In property & casualty, results can be volatile due to large losses (e.g., natural catastrophes) and prior-year reserve development; in life & health, profitability is influenced by mortality, morbidity, lapse/behavior assumptions, and longevity trends depending on the products reinsured. - Pricing and terms: Earnings are shaped by market pricing cycles (hard/soft markets), contract terms (limits, retentions, exclusions), and the mix of business (cat-exposed vs. non-cat, specialty lines, casualty long-tail vs. short-tail). - Fees/commissions and structured arrangements: Reinsurance contracts can involve ceding commissions and profit commissions (or experience accounts) depending on structure; these affect net underwriting margins. 2) Investment income (supporting earnings): - The company invests the float (premiums received and reserves held before claims are paid) in an investment portfolio. Returns come from interest income, dividends, and realized/unrealized gains and losses, depending on the accounting classification of assets. - The level of interest rates, credit spreads, equity market performance, and asset allocation materially influence investment results and, therefore, overall profitability. 3) Capital management effects (indirect contributors): - Reinsurers often use retrocession (reinsurance for reinsurers) to manage peak exposures; this can reduce volatility but also adds cost and impacts net earned premiums and net losses. - Earnings are also influenced by currency movements because the company writes business and holds assets globally. null

Hannover Rueck SE Financial Statement Overview

Summary

Moderate strength overall: balance sheet leverage looks manageable and operating cash flow was consistently strong through 2024. However, major 2025 inconsistencies (revenue spike, margin anomalies, and free cash flow dropping to zero) reduce confidence in the most recent trend signals.

Income Statement

Profitability looks solid on paper, with net income rising from 2020–2024 and strong net profit margins in 2022–2024. However, the revenue trend is highly inconsistent (sharp drop in 2022, modest recovery in 2024, then an extreme jump in 2025), and several margin figures appear unusually high versus revenue in multiple years (e.g., operating profit exceeding revenue), which reduces confidence in the quality/consistency of the underlying income statement signals.

Balance Sheet

Leverage appears manageable for a reinsurer: debt is moderate relative to equity in most years (about 0.3–0.6 in 2020–2024), equity has generally grown, and total assets are stable-to-up over time. The main weakness is data inconsistency in 2025 (debt-to-equity and return on equity shown as 0 despite meaningful debt/equity and positive earnings), which clouds the most recent-year read-through but does not negate the otherwise reasonable capitalization profile.

Cash Flow

Operating cash flow is consistently strong and fairly steady (roughly 3.2B–5.8B from 2020–2024), and free cash flow closely tracks earnings in those years. The key concern is 2025 showing free cash flow at 0 and a -100% growth rate versus prior year, indicating either a sharp deterioration or a reporting/data issue; that single-year break materially weakens the cash flow profile despite the prior multi-year consistency.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	27.68B	2.66B	1.13B	1.39B	26.15B
Gross Profit	27.68B	2.53B	1.04B	1.31B	20.39B
EBITDA	25.74B	3.37B	2.01B	1.44B	1.85B
Net Income	2.54B	2.33B	1.82B	780.80M	1.23B
Balance Sheet
Total Assets	71.30B	72.13B	65.67B	62.96B	82.90B
Cash, Cash Equivalents and Short-Term Investments	1.05B	57.39B	52.63B	46.65B	47.59B
Total Debt	4.14B	4.67B	4.88B	5.51B	4.37B
Total Liabilities	57.37B	59.44B	54.65B	53.00B	70.15B
Stockholders Equity	12.92B	11.79B	10.13B	9.06B	11.89B
Cash Flow
Free Cash Flow	0.00	5.68B	5.79B	5.16B	4.60B
Operating Cash Flow	5.46B	5.68B	5.79B	5.16B	4.94B
Investing Cash Flow	-3.89B	-4.41B	-4.51B	-5.38B	-5.26B
Financing Cash Flow	-1.65B	-1.10B	-1.50B	133.25M	277.51M

Hannover Rueck SE Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 47.27
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HVRRY, the sentiment is Positive. The current price of 47.27 is below the 20-day moving average (MA) of 49.50, below the 50-day MA of 48.51, and below the 200-day MA of 49.83, indicating a bullish trend. The MACD of 0.54 indicates Negative momentum. The RSI at 52.90 is Neutral, neither overbought nor oversold. The STOCH value of 61.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HVRRY.

Hannover Rueck SE Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ACGL	84 Outperform	$32.84B	7.15	19.02%	―	16.68%	-28.54%
RNR	80 Outperform	$12.64B	4.70	24.24%	0.57%	-3.96%	-48.08%
EG	75 Outperform	$12.76B	8.83	10.61%	2.37%	8.62%	-78.92%
RGA	73 Outperform	$12.98B	11.38	9.48%	1.76%	2.10%	19.23%
HVRRY	69 Neutral	$36.34B	12.65	21.53%	3.57%	4.35%	12.64%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
AIG	67 Neutral	$39.91B	15.62	7.50%	2.02%	-23.02%	52.43%